Read More

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.

ATRA

Read More

This Analyst With 87% Accuracy Rate Sees Around 11% Upside In Meta Platforms – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts

U.S. stocks closed higher on Friday, with the S&P 500 index hitting a new record high during the session. For the week, the S&P 500 gained 1.4%, recording gains for the fourth week in a row.

ALGM